Medimaps Group and Radiobotics Announce Strategic Merger to Expand AI-Driven Musculoskeletal Imaging Portfolio .
Medimaps Group and Radiobotics have announced a strategic merger aimed at expanding their combined portfolio of AI-driven musculoskeletal imaging technologies. The partnership brings together Medimaps’ expertise in bone health assessment and imaging analytics with Radiobotics’ artificial intelligence platforms for automated musculoskeletal image interpretation. By integrating their technologies, the companies aim to enhance diagnostic precision, streamline clinical workflows, and improve early detection of musculoskeletal conditions such as fractures, osteoarthritis, and osteoporosis. The merger reflects the growing role of artificial intelligence in orthopedic imaging, where automated analytics and decision-support tools are increasingly being used to support clinicians and improve efficiency across radiology and orthopedic care pathways.
Read the full News article from OrthoFeed
Read Article
AVIS DE NON-RESPONSABILITÉ
Le contenu de cette page est fourni à titre d'information uniquement et n'est pas destiné à remplacer un avis médical, un diagnostic ou un traitement professionnel. Si vous avez besoin d'un traitement médical, demandez toujours l'avis de votre médecin ou rendez-vous au service des urgences le plus proche. Les opinions, croyances et points de vue exprimés par les individus sur le contenu de cette page ne reflètent pas les opinions, croyances et points de vue d'OrthoEvidence.
